Stock ARBUTUS BIOPHARMA CORP
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MarketScreener Strategies Arbutus Biopharma Corp Nasdaq

Equities

CA87911B2093

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Arbutus Biopharma Corp
Jun. 06 Arbutus Biopharma Says Imdusiran Plus VTP-300 Therapy Lowers HBsAg Levels in Trial MT
Jun. 06 Arbutus Biopharma Corporation Announces New Preliminary End-Of- Treatment Data from the Phase 2A Clinical Trial CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABUS Stock
  4. Stock
  5. News Arbutus Biopharma Corp
  6. MarketScreener Strategies